Pharmaceutical industry productivity was robust in 2018, a year in which the US Food and Drug Administration approved a record 59 new drugs, with the regulatory environment becomeing more favorable to Big Pharma.
Pharmaceutical industry productivity was robust in 2018, a year in which the US Food and Drug Administration approved a record 59 new drugs, with the regulatory environment becomeing more favorable to Big Pharma.